发明公开
- 专利标题: SULFUR-CONTAINING BICYCLIC COMPOUND
- 专利标题(中): 含S双环CONNECTION
-
申请号: EP14853825.9申请日: 2014-10-17
-
公开(公告)号: EP3059239A1公开(公告)日: 2016-08-24
- 发明人: SHIRAISHI, Nobuyuki , HOSHII, Hiroaki , HAMAGUCHI, Wataru , HONJO, Eriko , TAKUWA, Tomofumi , KONDO, Yuji , GOTO, Takayuki
- 申请人: Astellas Pharma Inc.
- 申请人地址: 5-1, Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 JP
- 专利权人: Astellas Pharma Inc.
- 当前专利权人: Astellas Pharma Inc.
- 当前专利权人地址: 5-1, Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 103-8411 JP
- 代理机构: Bates, Philip Ian
- 优先权: JP2013216332 20131017
- 国际公布: WO2015056771 20150423
- 主分类号: C07D495/04
- IPC分类号: C07D495/04 ; A61K31/519 ; A61K31/5377 ; A61K31/541 ; A61K31/554 ; A61P25/00 ; A61P25/18 ; A61P25/22 ; A61P43/00 ; C07D519/00
摘要:
[Problem] Provided is a compound which is useful as a pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like.
[Means for Solution] The present inventors have studied that a pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like, which has a positive allosteric modulator (PAM action) of GABA B , and have found that a sulfur-containing bicyclic compound is a PAM of a GABA B receptor, thereby completing the present invention. The sulfur-containing bicyclic compound of the present invention has a PAM action of GABA B , and can be used as an agent for preventing and/or treating schizophrenia, CIAS, cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, or Charcot-Marie-Tooth disease.
[Means for Solution] The present inventors have studied that a pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like, which has a positive allosteric modulator (PAM action) of GABA B , and have found that a sulfur-containing bicyclic compound is a PAM of a GABA B receptor, thereby completing the present invention. The sulfur-containing bicyclic compound of the present invention has a PAM action of GABA B , and can be used as an agent for preventing and/or treating schizophrenia, CIAS, cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, or Charcot-Marie-Tooth disease.
公开/授权文献
- EP3059239B1 SULFUR-CONTAINING BICYCLIC COMPOUND 公开/授权日:2018-06-27
信息查询